Kinnate Biopharma Inc. 3 SEC Filings

Filed On	Filing
03 Mar 2023	Form 3: DeSimone Jill, Director No securities owned
23 Feb 2023	Form 3: OrbiMed Capital Gp Viii Llc, Director and 2 others Holds 550,000 shares of Common Stock
28 Jun 2021	Form 3: Sabzevari Helen, Director No securities owned
08 Jun 2021	Form 3: Krishnamohan Neha, Chief Financial Officer No securities owned
03 Dec 2020	Form 3: Foresite Capital Management IV, Llc, 10% owner and 5 others
02 Dec 2020	Form 3: Farzan Nima, Director
02 Dec 2020	Form 3: Mitchell Dean J, Director
02 Dec 2020	Form 3: Meltz Mark A, COO General Counsel Treasurer
02 Dec 2020	Form 3: Flaherty Keith T., Director Holds 66,377 shares of Common Stock
02 Dec 2020	Form 3: Epperly Melissa B,, Director
02 Dec 2020	Form 3: Kaldor Stephen W, Director Holds 1,615,826 shares of Common Stock
02 Dec 2020	Form 3: Williams Richard Thomas, Chief Medical Officer
02 Dec 2020	Form 3: Murphy Eric Anthony, Chief Scientific Officer Holds 1,615,826 shares of Common Stock
02 Dec 2020	Form 3: Gordon Carl L, Director
02 Dec 2020	Form 3: Smaldone Alsup Laurie, Director
02 Dec 2020	Form 3: Orbimed Advisors Llc, Director and 2 others
02 Dec 2020	Form 3: Tananbaum James B., Director
02 Dec 2020	Form 3: Rome Michael E, Director No securities owned

Comments